A nomogram for predicting lymph node metastasis in surgically resected T1 esophageal squamous cell carcinoma

Weiyu Shen, Yaxing Shen, Lijie Tan, Chenghua Jin, Yong Xi, Weiyu Shen, Yaxing Shen, Lijie Tan, Chenghua Jin, Yong Xi

Abstract

Background: Endoscopic therapies for T1 esophageal carcinoma have been increasingly used around the world. However, the procedures are limited by without lymph nodes harvested. The risk of lymph node metastasis (LNM) should been established. Our objective was to construct a nomogram model for predict risks of LNM in patients with pT1 esophageal squamous cell carcinoma (ESCC).

Methods: We reviewed the records of 221 patients with pT1 ESCC who underwent surgical resection and radical lymphadenectomy. Clinicopathological variables were analyzed univariate and multivariate logistic regression analysis. A nomogram for predicting risk of LNM was constructed and validated using bootstrap resampling.

Results: Of the 221 patients, 53 patients had been examined as LNM. Following multivariate analysis, poor differentiation (P=0.0006), lymphovascular invasion (P<0.0001) and SM3 (tumor invades the lower third of the submucosal layer) (P=0.0192) cancer were significantly independent risk factors for LNM and were entered into the nomogram. The nomogram showed a robust discrimination, with an area under the receiver operating characteristic curve (AUC) of 0.8667. The calibration curves for the probability of LNM showed optimal agreement between the probability as predicted by the nomogram and the actual probability.

Conclusions: We established a nomogram that can provide individual predicting for LNM in T1 ESCC, and this model has the potential clinical utility in making therapeutic procedures.

Keywords: T1; esophageal squamous cell carcinoma (ESCC); nomogram.

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Nomogram predicting risk of LNM in patients with T1 ESCC. LNM, lymph node metastasis; ESCC, esophageal squamous cell carcinoma.
Figure 2
Figure 2
The receiver operating characteristic (ROC) curve for the nomogram. The area under the ROC curve (AUC) =0.8667.
Figure 3
Figure 3
The calibration curves for the nomogram. The x-axis represents the nomogram-predicted probability and the y-axis represents the actual probability of LNM. LNM, lymph node metastasis.

References

    1. Bennett C, Vakil N, Bergman J, et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012;143:336-46. 10.1053/j.gastro.2012.04.032
    1. Molena D, DeMeester SR. The dilemma of T1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2017;153:1206-7. 10.1016/j.jtcvs.2016.10.106
    1. Louie BE. To resect or not to resect: The decision in T1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2017;153:1208 10.1016/j.jtcvs.2016.11.048
    1. Bennett C, Green S, Decaestecker J, et al. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett’s oesophagus. Cochrane Database Syst Rev 2012;11:CD007334.
    1. Ishihara R, Iishi H, Uedo NT, et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 2008;68:1066-72. 10.1016/j.gie.2008.03.1114
    1. Pech O, May A, Manner H, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014;146:652-60.e1. 10.1053/j.gastro.2013.11.006
    1. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 2007;65:3-10. 10.1016/j.gie.2006.04.033
    1. Dubecz A, Kern M, Solymosi N, et al. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer. Ann Thorac Surg 2015;99:1879-85; discussion 1886.
    1. Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006;19:475-80 10.1038/modpathol.3800557
    1. Grotenhuis BA, van Heijl M, Zehetner J, et al. Surgical management of submucosal esophageal cancer:extended or regional lymphadenectomy? Ann Surg 2010;252:823-30. 10.1097/SLA.0b013e3181fcd730
    1. Dutkowski P, Hommel G, Böttger T, et al. How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value. Hepatogastroenterology 2002;49:176-80.
    1. Li B, Chen H, Xiang J, et al. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2013;146:1198-203 10.1016/j.jtcvs.2013.07.006
    1. Liang W, Zhang L, Jiang G, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol 2015; 33:861-9. 10.1200/JCO.2014.56.6661
    1. Japan Esophageal Society. Japanese Classification of Esophageal Cancer (11th Edition: part I) Esophagus 2017;14:1-36.
    1. Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 2008; 26:1364-70. 10.1200/JCO.2007.12.9791
    1. Bandos AI, Rockette HE, Song T, et al. Area under the free-response ROC curve (FROC) and a related summary index. Biometrics 2009; 65:247-56. 10.1111/j.1541-0420.2008.01049.x
    1. Harrell FE, Jr, Lee KL, Mark DB, et al. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-87. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>;2-4
    1. Ozawa Y, Kamei T, Nakano T, et al. Characteristics of Postoperative Recurrence in Lymph Node-Negative Superficial Esophageal Carcinoma. World J Surg 2016;40:1663-71. 10.1007/s00268-016-3454-9
    1. Prasad GA, Wu TT, Wigle DA, et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology 2009;137:815-23. 10.1053/j.gastro.2009.05.059
    1. Samson P, Puri V, Lockhart AC, et al. Characteristics and outcomes of pathological node positive esophageal cancer patients receiving adjuvant chemotherapy following induction chemotherapy and esophagectomy. Presented at: 95th Annual Meeting of The American Association for Thoracic Surgery; May 14-18, 2016; Baltimore, MD.
    1. Manner H, Pech O, Heldmann Y, et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 2013;11:630-5. 10.1016/j.cgh.2012.12.040
    1. Boys JA, Worrell SG, Chandrasoma P, et al. Can the risk of lymph node metastases be gauged in endoscopically resected submucosal esophageal adenocarcinomas? A multi-center study. J Gastrointest Surg. 2016;20:6-12; discussion 12. 10.1007/s11605-015-2950-9
    1. Altorki NK, Lee PC, Liss Y, et al. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg 2008;247:434-9. 10.1097/SLA.0b013e318163a2ff
    1. Pennathur A, Farkas A, Krasinskas AM, et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg 2009;87:1048-54; discussion 1054-5. 10.1016/j.athoracsur.2008.12.060
    1. Bollschweiler E, Baldus SE, Schröder W, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006;38:149-56. 10.1055/s-2006-924993
    1. Ancona E, Rampado S, Cassaro M, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008;15:3278-88. 10.1245/s10434-008-0065-1
    1. Pech O, May A, Günter E, et al. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett’s esophagus. Am J Gastroenterol 2006;101:2223-9. 10.1111/j.1572-0241.2006.00718.x
    1. Pouw RE, Heldoorn N, Alvarez Herrero L, et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospecttive analysis of 131 cases. Gastrointest Endosc 2011;73:662-8. 10.1016/j.gie.2010.10.046
    1. Dhupar R, Rice RD, Correa AM, et al. Endoscopic ultrasound estimates for tumor depth at the gastroesophageal junction are inaccurate: implications for the liberal use of endoscopic resection. Ann Thorac Surg 2015;100:1812-6. 10.1016/j.athoracsur.2015.05.038
    1. Zhou W, Christiani DC. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer 329 between East Asians and Caucasians. Chin J Cancer 2011;30:287-92. 10.5732/cjc.011.10106

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe